Cargando…
The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells
BACKGROUND: Increased serum level of parathyroid hormone (PTH) was found in metastatic prostate cancers. Calcimimetic R-568 was reported to reduce PTH expression, to suppress cell proliferation and to induce apoptosis in parathyroid cells. In this study, we investigated the effect of R-568 on cellul...
Autores principales: | Li, Huaifu, Ruan, Guofeng, Li, Zhijun, Liu, Ziwei, Zheng, Xiaoqing, zheng, Hao, Cheng, Guangming, Li, Benyi, Zhan, Ming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716307/ https://www.ncbi.nlm.nih.gov/pubmed/19602280 http://dx.doi.org/10.1186/1756-9966-28-100 |
Ejemplares similares
-
Calcimimetic R-568 and Its Enantiomer S-568 Increase Nitric Oxide Release in Human Endothelial Cells
por: Bonomini, Mario, et al.
Publicado: (2012) -
Calcimimetic R568 reduced the blood pressure and improved aortic remodeling in spontaneously hypertensive rats by inhibiting local renin-angiotensin system activity
por: Sun, Ruixia, et al.
Publicado: (2018) -
Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs)
por: Di Pietro, Natalia, et al.
Publicado: (2018) -
Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013) -
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020)